Shape Therapeutics and Roche have entered into a strategic collaboration and license agreement to develop RNA-based gene therapies for…
Articles by Margarida Maia, PhD
Patient dosing has been completed in the Phase 2a clinical trial testing ANVS401, Annovis Bio’s investigational therapy for Alzheimer’s disease and …
A new hydrogel matrix appears to ease the delivery of therapeutic stem cells into the brain, a necessary step in…
Farnesol, a natural compound of some herbs and fruits in commercial use, was seen to protect nerve cells in the…
Inhibikase Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to start a Phase 1 clinical trial evaluating…
A committee of the European Medicines Agency (EMA) is recommending the refusal of marketing authorization for Nouryant (istradefylline) — approved…
A compound naturally found in turmeric essential oil, called aromatic turmerone (ar-turmerone), and its derivatives were seen to protect dopaminergic…
Training to dance to music on a weekly basis may slow the progression of both motor and non-motor symptoms of…
Therapeutic Solutions International has filed a patent for the use of a type of immune cell, called a dendritic…
Smoking history may not influence the severity of symptoms in Parkinson’s disease, a small study suggests. Moreover, in some individuals,…